NCT03162133View on ClinicalTrials.gov

Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

November 10, 2016

Primary Completion Date

November 10, 2017

Study Completion Date

November 10, 2018

Conditions
Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy
Interventions
OTHER

Baduanjin exercise

Trial Locations (1)

510080

Guangdong General Hospital, Guangzhou

All Listed Sponsors
collaborator

Guangzhou Sport University

OTHER

lead

Guangdong Provincial People's Hospital

OTHER

NCT03162133 - Evaluating the Impact of Baduanjin Exercise Intervention on Quality of Life in Breast Cancer Survivors Receiving Aromatase Inhibitor Therapy | Biotech Hunter | Biotech Hunter